New EU Partnership Project on Pain Patient Pathways Recommendations
Representatives from Patient Group, Civic Organisation and Industry enter into new collaborative project to improve the management of chronic pain in the EU
Brussels / Rome / Aachen, 20 November 2012. Pain Alliance Europe (PAE) representing chronic pain patients in Europe, Active Citizenship Network (ACN) and Grünenthal have entered into an official partnership on the development of European Pain Patient Pathways Recommendations. The projects will run until December 2014 and aims to create a greater awareness of chronic pain and to promote European policy-making for improved management of chronic pain.
While the political framework of the project is designed by PAE representing the patients’ voice in Europe, ACN will be responsible for the scientific design, methodology and contents. The pharmaceutical company Grünenthal will be responsible for financial and non-financial support.
“Chronic pain is a significant societal and economic burden in Europe: For the people affected, for their caregivers, but also for our health care systems”, explains Joop van Griensven, PAE President. “PAE’s mission is to improve the quality of life of people who have to live with chronic pain day by day. With this partnership patients all over Europe can work together to identify with all stakeholders best practice, accessibility and possibilities for effective pain treatment. By doing this we can develop a proposal for pain management for all European Member States in a joint and coordinated effort”.
Teresa Petrangolini, ACN Director and Project supervisor adds: “Civic participation is essential in the public policy-making process: Only an holistic approach respecting all stakeholders involved can produce realistic and implementable models for integration in our health-political systems. ACN has been working in this field for more than 30 years and we are proud to be able to join in this partnership and to support and strengthen the voice of chronic pain patients in Europe.”
“Concentrating exclusively on the therapy area of ‘pain’ Grünenthal’s objective is to become the most patient-centric company and a leader in therapy innovation”, comments Alberto Grua, Executive Vice President from Grünenthal Europe & Australia. “We feel privileged to enter into such a promising project which will create a bottom-up approach for effective and holistic pain management putting the patient in the centre of the whole process. PAE and ACN are two strong and internationally-acting patient and citizens’ groups and we will support their ideas and activities to ensure highest respect of the patients’ needs.”
More information is available on the ACN Project Website.
Here you can find the full European Press Release. Please read here the Italian Press Release, the Spanish Press Release, the Portuguese Press Release, the French Press Release, the Dutch Press Release or the German Press Release.